Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Plasma cysteine/cystine and glutathione/glutathione disulfide redox potentials in HIV and COPD patients.

Watson WH, Ritzenthaler JD, Peyrani P, Wiemken TL, Furmanek S, Reyes Vega AM, Burke TJ, Zheng Y, Ramirez JA, Roman J.

Free Radic Biol Med. 2019 Jul 29;143:55-61. doi: 10.1016/j.freeradbiomed.2019.07.031. [Epub ahead of print]

PMID:
31369840
2.

Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia.

Isturiz RE, Ramirez J, Self WH, Grijalva CG, Counselman FL, Volturo G, Ostrosky-Zeichner L, Peyrani P, Wunderink RG, Sherwin R, Overcash JS, Oliva SP, File T, Wiemken TL, McLaughlin JM, Pride MW, Gray S, Alexander R, Ford KD, Jiang Q, Jodar L.

Vaccine. 2019 May 31;37(25):3352-3361. doi: 10.1016/j.vaccine.2019.04.087. Epub 2019 May 6.

3.

Examining age as a moderating effect on the relationship between alcohol use and viral suppression among women living with HIV.

Crawford TN PhD, MPH, Harris LM PhD, MSW, Peyrani P MD.

Women Health. 2019 Aug;59(7):789-800. doi: 10.1080/03630242.2018.1553817. Epub 2019 Jan 7.

PMID:
30615579
4.

The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance.

Peyrani P, Mandell L, Torres A, Tillotson GS.

Expert Rev Respir Med. 2019 Feb;13(2):139-152. doi: 10.1080/17476348.2019.1562339. Epub 2018 Dec 30. Review.

PMID:
30596308
5.

Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia.

Arnold FW, Lopardo G, Wiemken TL, Kelley R, Peyrani P, Mattingly WA, Feldman C, Gnoni M, Maurici R, Ramirez JA; Community-Acquired Pneumonia Organization (CAPO).

Respir Med. 2018 Jul;140:115-121. doi: 10.1016/j.rmed.2018.05.020. Epub 2018 Jun 5.

PMID:
29957272
6.

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design.

McLaughlin JM, Jiang Q, Isturiz RE, Sings HL, Swerdlow DL, Gessner BD, Carrico RM, Peyrani P, Wiemken TL, Mattingly WA, Ramirez JA, Jodar L.

Clin Infect Dis. 2018 Oct 30;67(10):1498-1506. doi: 10.1093/cid/ciy312.

7.
8.

Future Research Directions in Pneumonia. NHLBI Working Group Report.

Dela Cruz CS, Wunderink RG, Christiani DC, Cormier SA, Crothers K, Doerschuk CM, Evans SE, Goldstein DR, Khatri P, Kobzik L, Kolls JK, Levy BD, Metersky ML, Niederman MS, Nusrat R, Orihuela CJ, Peyrani P, Prince AS, Ramírez JA, Ridge KM, Sethi S, Suratt BT, Sznajder JI, Tsalik EL, Walkey AJ, Yende S, Aggarwal NR, Caler EV, Mizgerd JP.

Am J Respir Crit Care Med. 2018 Jul 15;198(2):256-263. doi: 10.1164/rccm.201801-0139WS.

9.

Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial.

Winston A, Post FA, DeJesus E, Podzamczer D, Di Perri G, Estrada V, Raffi F, Ruane P, Peyrani P, Crofoot G, Mallon PWG, Castelli F, Yan M, Cox S, Das M, Cheng A, Rhee MS.

Lancet HIV. 2018 Apr;5(4):e162-e171. doi: 10.1016/S2352-3018(18)30010-9. Epub 2018 Feb 20.

10.

Telavancin for the treatment of methicillin-resistant Staphylococcus aureus bone and joint infections.

Harting J, Fernandez F, Kelley R, Wiemken T, Peyrani P, Ramirez J.

Diagn Microbiol Infect Dis. 2017 Dec;89(4):294-299. doi: 10.1016/j.diagmicrobio.2017.09.004. Epub 2017 Sep 18.

PMID:
29137718
11.

Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States.

Campbell EM, Jia H, Shankar A, Hanson D, Luo W, Masciotra S, Owen SM, Oster AM, Galang RR, Spiller MW, Blosser SJ, Chapman E, Roseberry JC, Gentry J, Pontones P, Duwve J, Peyrani P, Kagan RM, Whitcomb JM, Peters PJ, Heneine W, Brooks JT, Switzer WM.

J Infect Dis. 2017 Nov 27;216(9):1053-1062. doi: 10.1093/infdis/jix307.

12.

Adults Hospitalized With Pneumonia in the United States: Incidence, Epidemiology, and Mortality.

Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM; University of Louisville Pneumonia Study Group.

Clin Infect Dis. 2017 Nov 13;65(11):1806-1812. doi: 10.1093/cid/cix647.

PMID:
29020164
13.

Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study.

Aliberti S, Morlacchi LC, Faverio P, Fernandez-Botran R, Cosentini R, Mantero M, Peyrani P, Ramirez J, Bordon J, Blasi F.

Pneumonia (Nathan). 2016 Jun 23;8:8. doi: 10.1186/s41479-016-0009-7. eCollection 2016.

14.

The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization.

Peyrani P, Wiemken TL, Metersky ML, Arnold FW, Mattingly WA, Feldman C, Cavallazzi R, Fernandez-Botran R, Bordon J, Ramirez JA.

Infect Dis (Lond). 2018 Jan;50(1):13-20. doi: 10.1080/23744235.2017.1350881. Epub 2017 Jul 12.

PMID:
28699429
15.

Long-term Mortality in Hospitalized Patients With Community-Acquired Pneumonia.

Peyrani P, Ramirez J.

Am J Med Sci. 2017 May;353(5):421. doi: 10.1016/j.amjms.2017.04.008. No abstract available.

PMID:
28502325
16.

Infection prevention and control and the refugee population: Experiences from the University of Louisville Global Health Center.

Carrico RM, Goss L, Wiemken TL, Bosson RS, Peyrani P, Mattingly WA, Pauly A, Ford RA, Kotey S, Ramirez JA.

Am J Infect Control. 2017 Jun 1;45(6):673-676. doi: 10.1016/j.ajic.2017.02.032. Epub 2017 Apr 18.

PMID:
28431845
17.

Using cluster analysis of cytokines to identify patterns of inflammation in hospitalized patients with community-acquired pneumonia: a pilot study.

Wiemken TL, Kelley RR, Fernandez-Botran R, Mattingly WA, Arnold FW, Furmanek SP, Restrepo MI, Chalmers JD, Peyrani P, Cavallazzi R, Bordon J, Aliberti S, Ramirez JA.

Univ Louisville J Respir Infect. 2017;1(1):3-11. doi: 10.18297/jri/vol1/iss1/1/. Epub 2017 Jan 30.

18.

Respiratory Health in Migrant Populations: A Crisis Overlooked.

Holguin F, Moughrabieh MA, Ojeda V, Patel SR, Peyrani P, Pinedo M, Celedón JC, Douglas IS, Upson DJ, Roman J.

Ann Am Thorac Soc. 2017 Feb;14(2):153-159. doi: 10.1513/AnnalsATS.201608-592PS. Review.

19.

Comparing posteroanterior with lateral and anteroposterior chest radiography in the initial detection of parapneumonic effusions.

Moffett BK, Panchabhai TS, Nakamatsu R, Arnold FW, Peyrani P, Wiemken T, Guardiola J, Ramirez JA.

Am J Emerg Med. 2016 Dec;34(12):2402-2407. doi: 10.1016/j.ajem.2016.09.021. Epub 2016 Sep 14.

PMID:
27793503
20.

Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia.

Aliberti S, Ramirez J, Cosentini R, Valenti V, Voza A, Rossi P, Stolz D, Legnani D, Pesci A, Richeldi L, Peyrani P, Massari FM, Blasi F.

ERJ Open Res. 2015 Sep 15;1(1). pii: 00020-2015. eCollection 2015 May.

21.

The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia.

Luna CM, Palma I, Niederman MS, Membriani E, Giovini V, Wiemken TL, Peyrani P, Ramirez J.

Ann Am Thorac Soc. 2016 Sep;13(9):1519-26. doi: 10.1513/AnnalsATS.201512-848OC.

PMID:
27398827
22.

Real-Time Enrollment Dashboard For Multisite Clinical Trials.

Mattingly WA, Kelley RR, Wiemken TL, Chariker JH, Peyrani P, Guinn BE, Binford LE, Buckner K, Ramirez J.

Contemp Clin Trials Commun. 2015 Oct 30;1:17-21.

23.

Understanding why low-risk patients accept vaccines: a socio-behavioral approach.

Wiemken TL, Carrico RM, Kelley RR, Binford LE, Peyrani P, Ford KD, Welch V, Ramirez JA.

BMC Res Notes. 2015 Dec 23;8:813. doi: 10.1186/s13104-015-1816-2.

24.

Macrolide Use and Neutrophil Function/Cytokine Levels in Hospitalized Patients with Community-Acquired Pneumonia: A Pilot Study.

Arnold FW, Bordon J, Fernandez-Botran R, Rane MJ, Uriarte SM, Kelley R, Wiemken TL, Peyrani P, Ramirez JA; Community-Acquired Pneumonia Inflammatory Study Group.

Lung. 2016 Feb;194(1):155-62. doi: 10.1007/s00408-015-9822-7. Epub 2015 Nov 9.

PMID:
26553025
25.

Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.

Bordon JM, Fernandez-Botran R, Wiemken TL, Peyrani P, Uriarte SM, Arnold FW, Rodriquez-Hernandez L, Rane MJ, Kelley RR, Binford LE, Uppatla S, Cavallazzi R, Blasi F, Aliberti S, Restrepo MI, Fazeli S, Mathur A, Rahmani M, Ayesu K, Ramirez J.

Infection. 2015 Dec;43(6):729-38. doi: 10.1007/s15010-015-0837-z. Epub 2015 Sep 30.

PMID:
26424683
26.

De-escalation therapy among bacteraemic patients with community-acquired pneumonia.

Carugati M, Franzetti F, Wiemken T, Kelley RR, Peyrani P, Blasi F, Ramirez J, Aliberti S.

Clin Microbiol Infect. 2015 Oct;21(10):936.e11-8. doi: 10.1016/j.cmi.2015.06.015. Epub 2015 Jun 23. Erratum in: Clin Microbiol Infect. 2015 Dec;21(12):e87. Kelly, R [corrected to Kelley, R R].

27.

What is the best therapeutic approach to methicillin-resistant Staphylococcus aureus pneumonia?

Peyrani P, Ramirez J.

Curr Opin Infect Dis. 2015 Apr;28(2):164-70. doi: 10.1097/QCO.0000000000000149. Review.

PMID:
25692268
28.

Efficacy of a novel skin antiseptic against carbapenem-resistant Enterobacteriaceae.

Wiemken TL, Kelley RR, Carrico RM, Binford LE, Guinn BE, Mattingly WA, Peyrani P, Ramirez JA.

Am J Infect Control. 2015 Apr 1;43(4):380-2. doi: 10.1016/j.ajic.2014.12.007. Epub 2015 Feb 7.

PMID:
25660077
29.

Characteristics associated with clinician diagnosis of aspiration pneumonia: a descriptive study of afflicted patients and their outcomes.

Lanspa MJ, Peyrani P, Wiemken T, Wilson EL, Ramirez JA, Dean NC.

J Hosp Med. 2015 Feb;10(2):90-6. doi: 10.1002/jhm.2280. Epub 2014 Nov 1.

30.

Evaluation of the effectiveness of improved hydrogen peroxide in the operating room.

Wiemken TL, Curran DR, Kelley RR, Pacholski EB, Carrico RM, Peyrani P, Khan MS, Ramirez JA.

Am J Infect Control. 2014 Sep;42(9):1004-5. doi: 10.1016/j.ajic.2014.05.002. Epub 2014 Jun 14.

PMID:
24939514
31.

Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study.

Peyrani P, Wiemken TL, Kelley R, Zervos MJ, Kett DH, File TM Jr, Stein GE, Ford KD, Scerpella EG, Welch V, Ramirez JA; IMPACT-HAP Study Group.

Crit Care. 2014 Jun 10;18(3):R118. doi: 10.1186/cc13914.

32.

Ruling out Legionella in community-acquired pneumonia.

Haubitz S, Hitz F, Graedel L, Batschwaroff M, Wiemken TL, Peyrani P, Ramirez JA, Fux CA, Mueller B, Schuetz P.

Am J Med. 2014 Oct;127(10):1010.e11-9. doi: 10.1016/j.amjmed.2014.03.042. Epub 2014 May 6.

PMID:
24813862
33.

The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study.

Wiemken TL, Carrico RM, Klein SL, Jonsson CB, Peyrani P, Kelley RR, Aliberti S, Blasi F, Fernandez-Gonzalez R, Lopardo G, Ramirez JA; CAPO Investigators.

Vaccine. 2014 Apr 17;32(19):2198-203. doi: 10.1016/j.vaccine.2014.02.048. Epub 2014 Mar 6.

PMID:
24613522
34.

Contrasting inflammatory responses in severe and non-severe community-acquired pneumonia.

Fernandez-Botran R, Uriarte SM, Arnold FW, Rodriguez-Hernandez L, Rane MJ, Peyrani P, Wiemken T, Kelley R, Uppatla S, Cavallazzi R, Blasi F, Morlacchi L, Aliberti S, Jonsson C, Ramirez JA, Bordon J.

Inflammation. 2014 Aug;37(4):1158-66. doi: 10.1007/s10753-014-9840-2.

PMID:
24557760
35.

The role of infection prevention conferences to build and maintain knowledge-sharing networks: a longitudinal evaluation.

Wiemken TL, Kelley RR, Pacholski EB, Carrico KW, Peyrani P, Carrico RM, Ramirez JA.

Am J Infect Control. 2014 Feb;42(2):209-11. doi: 10.1016/j.ajic.2013.07.018. Epub 2013 Dec 17.

PMID:
24355491
36.

A worldwide perspective of nursing home-acquired pneumonia compared with community-acquired pneumonia.

Liapikou A, Polverino E, Cilloniz C, Peyrani P, Ramirez J, Menendez R, Torres A; Community-Acquired Pneumonia Organization (CAPO) Investigators.

Respir Care. 2014 Jul;59(7):1078-85. doi: 10.4187/respcare.02788. Epub 2013 Nov 5.

37.

Absence of gender-based differences in outcome of patients with hospital-acquired pneumonia.

Caceres F, Welch VL, Kett DH, Scerpella EG, Peyrani P, Ford KD, Ramirez JA; Impact-Hap Study Group.

J Womens Health (Larchmt). 2013 Dec;22(12):1069-75. doi: 10.1089/jwh.2013.4434. Epub 2013 Oct 15.

PMID:
24128006
38.

Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia.

Cavallazzi R, Wiemken T, Christensen D, Peyrani P, Blasi F, Levy G, Aliberti S, Kelley R, Ramirez J; Community-Acquired Pneumonia Organization (CAPO) Investigators.

Eur Respir J. 2014 Jan;43(1):178-84. doi: 10.1183/09031936.00017813. Epub 2013 Jun 21.

39.

Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study.

Arnold FW, Wiemken TL, Peyrani P, Ramirez JA, Brock GN; CAPO authors.

Respir Med. 2013 Jul;107(7):1101-11. doi: 10.1016/j.rmed.2013.04.003. Epub 2013 May 6.

40.

Cytokines and neutrophils responses in influenza pneumonia.

Bordon JM, Uriarte S, Arnold FW, Fernandez-Botran R, Rane M, Peyrani P, Cavallazzi R, Saad M, Ramirez J.

Infection. 2013 Oct;41(5):1021-4. doi: 10.1007/s15010-013-0461-8. Epub 2013 Apr 16.

PMID:
23589279
41.

Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes.

Bordon J, Aliberti S, Duvvuri P, Wiemken T, Peyrani P, Natividad I, Caceres-Lara A, Delapenha R, Blasi F, Ramirez J.

Int J Infect Dis. 2013 May;17(5):e293-8. doi: 10.1016/j.ijid.2012.09.021. Epub 2013 Mar 16.

42.

Phenotypic differences in virulence and immune response in closely related clinical isolates of influenza A 2009 H1N1 pandemic viruses in mice.

Camp JV, Chu YK, Chung DH, McAllister RC, Adcock RS, Gerlach RL, Wiemken TL, Peyrani P, Ramirez JA, Summersgill JT, Jonsson CB.

PLoS One. 2013;8(2):e56602. doi: 10.1371/journal.pone.0056602. Epub 2013 Feb 18.

43.

What is the association of cardiovascular events with clinical failure in patients with community-acquired pneumonia?

Peyrani P, Ramirez J.

Infect Dis Clin North Am. 2013 Mar;27(1):205-10. doi: 10.1016/j.idc.2012.11.010. Review.

PMID:
23398875
44.

Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA.

Pasquale TR, Jabrocki B, Salstrom SJ, Wiemken TL, Peyrani P, Haque NZ, Scerpella EG, Ford KD, Zervos MJ, Ramirez JA, File TM Jr; IMPACT-HAP Study Group.

Int J Infect Dis. 2013 Jun;17(6):e398-403. doi: 10.1016/j.ijid.2012.12.013. Epub 2013 Feb 1.

45.

Incidence of respiratory viruses in patients with community-acquired pneumonia admitted to the intensive care unit: results from the Severe Influenza Pneumonia Surveillance (SIPS) project.

Wiemken T, Peyrani P, Bryant K, Kelley RR, Summersgill J, Arnold F, Carrico R, McKinney WP, Jonsson C, Carrico K, Ramirez J.

Eur J Clin Microbiol Infect Dis. 2013 May;32(5):705-10. doi: 10.1007/s10096-012-1802-8. Epub 2012 Dec 30.

PMID:
23274861
46.

Criteria for clinical stability in hospitalised patients with community-acquired pneumonia.

Aliberti S, Zanaboni AM, Wiemken T, Nahas A, Uppatla S, Morlacchi LC, Peyrani P, Blasi F, Ramirez J.

Eur Respir J. 2013 Sep;42(3):742-9. doi: 10.1183/09031936.00100812. Epub 2012 Nov 8.

47.

Empiric therapy directed against MRSA in patients admitted to the intensive care unit does not improve outcomes in community-acquired pneumonia.

Griffin AT, Peyrani P, Wiemken TL, Ramirez JA, Arnold FW.

Infection. 2013 Apr;41(2):517-23. doi: 10.1007/s15010-012-0363-1. Epub 2012 Nov 7.

PMID:
23132663
48.

A three-step critical pathway for community-acquired pneumonia reduces duration of hospital stay and intravenous antibiotic use by 2 days.

Peyrani P.

Evid Based Nurs. 2013 Apr;16(2):48-9. doi: 10.1136/eb-2012-101000. Epub 2012 Oct 25.

PMID:
23100261
49.

Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia.

Bordon J, Aliberti S, Fernandez-Botran R, Uriarte SM, Rane MJ, Duvvuri P, Peyrani P, Morlacchi LC, Blasi F, Ramirez JA.

Int J Infect Dis. 2013 Feb;17(2):e76-83. doi: 10.1016/j.ijid.2012.06.006. Epub 2012 Oct 12. Review.

50.

Outcomes in females hospitalised with community-acquired pneumonia are worse than in males.

Arnold FW, Wiemken TL, Peyrani P, Mirsaeidi M, Ramirez JA; Community Acquired Pneumonia Organization (CAPO) Study Group.

Eur Respir J. 2013 May;41(5):1135-40. doi: 10.1183/09031936.00046212. Epub 2012 Jul 26.

Supplemental Content

Loading ...
Support Center